Estrogens realize their HTN-protective phenotypic effects through vasoconstriction/vasodilation mechanisms due to the regulation of the renin–angiotensin–aldosterone system, the production of catecholamines, endothelins and angiotensin II [91,92,93]. The gene discussed is AGT; the disease is hypertensive disorder.